These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38070601)
1. Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions. Li L; Wu X; Wu J; Zhang X; Miao F; Wang J; Lu J; Liu J; Chen Z; Tai Z; Zhu Q J Control Release; 2024 Jan; 365():818-832. PubMed ID: 38070601 [TBL] [Abstract][Full Text] [Related]
2. Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model. Peng L; Li Q; Wang H; Wu J; Li C; Liu Y; Liu J; Xia L; Xia Y Cell Death Dis; 2018 Jul; 9(8):801. PubMed ID: 30038329 [TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation. Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384 [TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ. Gunderson AJ; Mohammed J; Horvath FJ; Podolsky MA; Anderson CR; Glick AB J Invest Dermatol; 2013 Apr; 133(4):955-63. PubMed ID: 23151849 [TBL] [Abstract][Full Text] [Related]
5. Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition. Hayakawa K; Maeda T; Egusa C; Okubo Y; Harada K Exp Dermatol; 2023 Jun; 32(6):878-888. PubMed ID: 36928929 [TBL] [Abstract][Full Text] [Related]
6. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment. Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227 [TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations. Mandal A; Kumbhojkar N; Reilly C; Dharamdasani V; Ukidve A; Ingber DE; Mitragotri S Sci Adv; 2020 Jul; 6(30):eabb6049. PubMed ID: 32832675 [TBL] [Abstract][Full Text] [Related]
8. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Lovato P; Norsgaard H; Tokura Y; Røpke MA J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805 [TBL] [Abstract][Full Text] [Related]
9. Zhang H; Ren C; Liu Q; Wang Q; Wang D Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570 [TBL] [Abstract][Full Text] [Related]
10. Topical delivery of siRNA into skin using ionic liquids. Dharamdasani V; Mandal A; Qi QM; Suzuki I; Bentley MVLB; Mitragotri S J Control Release; 2020 Jul; 323():475-482. PubMed ID: 32339547 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine facilitates the pathogenesis of psoriasis through activating keratinocytes and T cells differentiation via glycolysis. Liu P; Zhou Y; Chen C; Yan B; Li L; Zhu W; Li J; Chen M; Su J; Kuang Y; Chen X; Peng C J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1344-1360. PubMed ID: 37013729 [TBL] [Abstract][Full Text] [Related]
12. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis. Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890 [TBL] [Abstract][Full Text] [Related]
14. Curcumin-Based Ionic Liquid Hydrogel for Topical Transdermal Delivery of Curcumin To Improve Its Therapeutic Effect on the Psoriasis Mouse Model. Lu B; Zhong Y; Zhang J; Zhang J ACS Appl Mater Interfaces; 2024 Apr; 16(14):17080-17091. PubMed ID: 38557004 [TBL] [Abstract][Full Text] [Related]
15. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. Koegel H; von Tobel L; Schäfer M; Alberti S; Kremmer E; Mauch C; Hohl D; Wang XJ; Beer HD; Bloch W; Nordheim A; Werner S J Clin Invest; 2009 Apr; 119(4):899-910. PubMed ID: 19307725 [TBL] [Abstract][Full Text] [Related]
16. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes. Antal D; Pór Á; Kovács I; Dull K; Póliska S; Ujlaki G; Demény MÁ; Szöllősi AG; Kiss B; Szegedi A; Bai P; Szántó M J Mol Med (Berl); 2023 Aug; 101(8):987-999. PubMed ID: 37351597 [TBL] [Abstract][Full Text] [Related]
17. TWEAK/Fn14 Activation Participates in Skin Inflammation. Liu Q; Xiao S; Xia Y Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621 [TBL] [Abstract][Full Text] [Related]
18. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548 [TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of T cells in the peripheral circulation in psoriasis. Priyadarssini M; Divya Priya D; Indhumathi S; Rajappa M; Chandrashekar L; Thappa DM Br J Biomed Sci; 2016 Oct; 73(4):174-179. PubMed ID: 27477596 [TBL] [Abstract][Full Text] [Related]
20. CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-κB signaling for the treatment of psoriasis. Zhao J; Chen Y; Li L; Yin H; Song S; Wang Y; Feng X; Fan X; Gao C; Gao L; Zhan Y; Zhao M; Li X; Lu Q Int J Biol Sci; 2024; 20(6):2168-2186. PubMed ID: 38617532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]